Skip to main content
Clinical Trials/PACTR202007465309582
PACTR202007465309582
Completed
Phase 3

Effect of concurent training (strength and endurance) on biochemical and neurophysiological adaptations and physical and psycho-cognitive performance in people with multiple sclerosis: role of melatonin or synbiotics supplementation

The Research Unit of the assessment of musculoskeletal disorders0 sites60 target enrollmentJune 3, 2020

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
The Research Unit of the assessment of musculoskeletal disorders
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 3, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The Research Unit of the assessment of musculoskeletal disorders

Eligibility Criteria

Inclusion Criteria

  • \*Patients under 60 years old
  • \*Sedentary.
  • \*EDSS : from 0 to 5
  • \*Body mass index (BMI) \<30 (kg/m²)

Exclusion Criteria

  • \* 3 months before the study: Taking another supplement, antioxidant substances, vitamins or anti\-inflammatory drugs.
  • \* No hormonal treatments or sleeping pills (hypnotics and anxiolytics) two weeks before the study \* Patients who have undergone a rehabilitation protocol in the previous 6 months
  • \*A contraindication or an allergy to melatonin or probiotics
  • \* Smoking, alcoholism, drugs \* Other chronic or autoimmune neurodegenerative comorbidities. \* Diabetes, osteoporosis, other neurological, vestibular, cognitive, orthopedic, visual and psychiatric disorders.
  • \*Any contraindication to the practice of a physical activity (serious cardiovascular or pulmonary diseases, an exacerbation of the MS in the 4 weeks preceding the tests)
  • \*EDSS\> or \= 6 (Dependent patients or use assistive devices) \* Pregnant or lactating women in the last six months,
  • \*Patients with nephrolithiasis in the last 5 years (related to synbiotic) \* Women with irregular menstruation and unwilling to use appropriate contraception

Outcomes

Primary Outcomes

Not specified

Similar Trials